Comment submitted by Daniel Axelrad et al.
AnonymousOpposeAcademic
Summary: A group of scientists, academics, and clinicians, including representatives from Stanford University, argue that the EPA's draft risk evaluation for HHCB fails to use the "best available science." They contend that the EPA used deficient study quality metrics, ignored significant health hazards like thyroid effects, and relied on industry-aligned frameworks to downplay risks.
Please see the attached comments from the Woodruff Science Policy Lab at Stanford University, academics, scientists, health professionals, and clinicians.